Patent · US Expired

Benzimidazol derivatives modulate chemokine receptors

US7388020B2 · kind B2 · utility

3Cited by

22References

25Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Tomas Eriksson · Kvicksund, SE
Svetlana Ivanova · Lund, SE
Hans Roland LONN · Lund, SE

Key dates

Filing date	Mar 18, 2002
Grant date	Jun 17, 2008
Priority date	—
Expiry date	Sep 2, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compounds of general formula (I) wherein A, X, m, R1, N, R2, Z1, Z2, Q, R3, R4, R5, R6, R7, R8, t and R16 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.